Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunogenetics in liver disease

P T Donaldson1

  • 1Institute of Liver Studies, King's College Hospital, London, UK.

Bailliere'S Clinical Gastroenterology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Human leukocyte antigen (HLA) associations reveal genetic factors influencing autoimmune and chronic viral liver diseases. Specific HLA alleles and amino acid substitutions impact susceptibility, resistance, and prognosis in conditions like autoimmune hepatitis and primary sclerosing cholangitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis.

Tissue antigens·2007
Same author

Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection.

Gut·2005
Same author

Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease.

Gut·2005
Same author

Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study.

Liver international : official journal of the International Association for the Study of the Liver·2004
Same author

The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.

The Journal of clinical endocrinology and metabolism·2004
Same author

Genetics of liver disease: immunogenetics and disease pathogenesis.

Gut·2004
Same journal

Index.

Bailliere's clinical gastroenterology·2020
Same journal

Home enteral and parenteral nutrition in children.

Bailliere's clinical gastroenterology·1999
Same journal

Nutritional support in malnourished paediatric patients.

Bailliere's clinical gastroenterology·1999
Same journal

Cholestasis and end-stage liver disease.

Bailliere's clinical gastroenterology·1999
Same journal

Cystic fibrosis: nutritional consequences and management.

Bailliere's clinical gastroenterology·1999
Same journal

Pancreatic diseases (excluding cystic fibrosis).

Bailliere's clinical gastroenterology·1999
See all related articles

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Cellular Immunology

Background:

  • Advances in molecular biology, including X-ray crystallography and PCR-based HLA genotyping, have transformed immunogenetics.
  • Molecular immunogenetics refines understanding of HLA-encoded susceptibility and resistance in autoimmune and chronic viral liver diseases.

Purpose of the Study:

  • To explore the role of human leukocyte antigen (HLA) associations in the susceptibility, resistance, and prognosis of autoimmune and chronic viral liver diseases.
  • To identify specific amino acid substitutions and HLA alleles linked to autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), primary biliary cirrhosis (PBC), and chronic viral hepatitis.

Main Methods:

  • Utilizing X-ray crystallography of purified antigens (A2, DR1).
  • Employing PCR-based HLA genotyping techniques.

Related Experiment Videos

  • Analyzing amino acid residue substitutions in HLA DR beta-polypeptide and DP beta-polypeptide.
  • Main Results:

    • Specific amino acid substitutions in HLA DR beta-polypeptide (AIH, PSC) and DP beta-polypeptide (PBC) are linked to disease susceptibility or resistance.
    • The lysine residue at DR beta 71 is confirmed as a susceptibility factor for AIH.
    • Resistance to chronic hepatitis B is associated with HLA DRB1*1302; DQA1*03 and DQB1*05 may protect against chronic hepatitis C.

    Conclusions:

    • HLA associations provide insights into the pathogenesis of liver diseases.
    • Specific HLA haplotypes (e.g., DRB1*0301-DRB3*0101 in AIH, DRB3*0101 and DRB1*0401 in PSC) are linked to disease severity and progression.
    • Further research is needed to fully elucidate immunogenetic susceptibility in liver disease.